US OptionsDetailed Quotes
RMTI241220C7500
- 0.05
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume115 Open Interest7.50Strike Price0.00Turnover260.57%IV235.56%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0883Delta0.1010Gamma45.00Leverage Ratio-0.0047Theta0.0001Rho3.97Eff Leverage0.0010Vega
Rockwell Medical Stock Discussion
$Baxter International Inc (BAX.US)$
$Fresenius Medical Care (FMS.US)$
$Rockwell Medical (RMTI.US)$ (adj ind.)
$Compass Minerals (CMP.US)$
(chemical for saline)
ADD meds:
$Teva Pharmaceutical Industries (TEVA.US)$
$Pfizer (PFE.US)$
$Cingulate (CING.US)$
EVH (endoscopic vessel harvesting) device shortage:
$TransMedics (TMDX.US)$
$Artivion (AORT.US)$
$Lantheus (LNTH.US)$
$Haemonetics (HAE.US)$
BGM (Blood glucose monitor) device shortage:
$DexCom (DXCM.US)$ $
$Abbott Laboratories (ABT.US)$
...
Risk Level: 6 (Moderate Risk)
The stock carries a moderate risk level of 6, indicating it is neither excessively risky nor completely safe. The company has a moderately profitable status with strong operational earnings and a good cash position, which counters the negative P/E ratio due to recent losses. Recent earnings for the company indicate profitability, aided by a net income of $1.66M for Q3 2024 and an EPS of $0.05. The positive catalyst , as the expansion of...
An aggregate of 5,643,340 shares of our common stock are sold at a price of $4.43 per share, the last reported sale price of our common stock on the Nasdaq Capital Market on November 8, 2024, for aggregate gross proceeds of $25 million. The shares sold in this offering, if any, will be sold from time to time at various prices. An increase of $1.00 per share in the price at which the shares are sold from the assumed offering price o...
No comment yet